Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.

PURPOSE: Heavy-atom-enhanced synchrotron stereotactic radiotherapy (SSR) is a treatment that involves selective accumulation of high-Z elements in tumors followed by stereotactic irradiation with X-rays from a synchrotron source. The purpose of this study was to determine whether the efficacy of iodine-enhanced SSR could be further improved in the F98 rodent glioma model, by using a concomitant injection of an iodinated contrast agent and a transient blood-brain barrier opener (mannitol) during irradiation. METHODS AND MATERIALS: Fourteen days after intracerebral inoculations of F98 cells, the rats were irradiated with 50-keV X-rays while receiving an infusion of hyperosmotic mannitol with iodine, either intravenously or via the carotid (9 to 15 rats per group, 117 rats total). RESULTS: For doses

Domains

Life Sciences [q-bio] Cancer

Embargoed file

Ne sera jamais visible

Raphael Serduc : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00388754

Submitted on : Thursday, October 15, 2009-9:51:25 AM

Last modification on : Thursday, October 13, 2022-3:06:38 PM

Long-term archiving on: Saturday, November 26, 2016-8:55:22 AM

Dates and versions

inserm-00388754 , version 1 (15-10-2009)

Identifiers

HAL Id : inserm-00388754 , version 1
DOI : 10.1016/j.ijrobp.2005.09.004
PUBMED : 16338098

Cite

Jean-François Adam, Aurélie Joubert, Marie-Claude Biston, Anne-Marie Charvet, Michel Peoc'H, et al.. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.. International Journal of Radiation Oncology, Biology, Physics, 2006, 64 (2), pp.603-11. ⟨10.1016/j.ijrobp.2005.09.004⟩. ⟨inserm-00388754⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UGA U836

117 View

0 Download